MetaMedical™ Solutions Inc

Bloomlife receives FDA clearance for Bloomlife MFM-Pro device

Maternal health company Bloomlife has announced the US Food and Drug Administration (FDA) clearance of its Bloomlife MFM-Pro device.

The Bloomlife MFM-Pro prescription-based wearable device is designed to monitor maternal and fetal heart rates, facilitating care in both home and clinical settings.

It can non-invasively measure the body’s electrical activity and uses cloud-based processing to algorithmically extract maternal and fetal heart rates.

Bloomlife co-founder and CEO Eric Dy said: “Our pioneering consumer pregnancy tracker proved that women want access to more information during a pivotal time of their life. The FDA clearance of Bloomlife MFM-Pro marks an important milestone by cementing our transition from consumer to medical markets.”

The latest approval follows Bloomlife’s partnership with Perigen to improve access to essential high-risk pregnancy monitoring.

The partnership, which was announced earlier this month, will combine remote patient monitoring and AI-driven analytics to bring cost-effective procedures to patients.

Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free

Your download email will arrive shortly

We are confident about the
quality of our Company Profiles. However, we want you to make the most
decision for your business, so we offer a free sample that you can download by
submitting the below form

By GlobalData

Bloomlife said it aims to leverage technology to shift care from high-cost clinical environments to the home, aiming to provide evidence-based, cost-effective, high-quality, patient-centered care.

Dy added: “Covid revealed a significant amount of maternal care can be done outside of clinical settings. However, there remains a need to augment basic telehealth appointments with objective physiological data.

“Utilisation of connected care solutions can not only increase the quality of virtual appointments, but allow us to build a more efficient, equitable, and scalable means of screening and managing the health of mom and baby.”

Bloomlife designs solutions for remote maternal health to improve the health and well-being of mothers and babies.

Source link